Cellectar Biosciences, Inc.
USD2.52
+0.01 (+0.40%)
CEO
James V. Caruso
IPO Date
2005-11-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.51
Prev. Close
$2.51
Day Low
$2.48
Day High
$2.55
52W Low
$2.20
52W High
$6.52
Market Cap
$0.01B
Volume
0.01M
| 92,000 |
| $3.14 |
| 8 Jul 2026 | DRISCOLL FREDERICK W | director | A-Award | Acquired | 25,000 | $2.70 |
| 8 Jul 2026 | Chanan-Khan Asher | director | A-Award | Acquired | 25,000 | $2.70 |
| 8 Jul 2026 | CARUSO JAMES V | director, officer: President & CEO | A-Award | Acquired | 250,000 | $3.14 |
| 8 Jul 2026 | Gu Andrew | director | A-Award | Acquired | 25,000 | $2.70 |
| 8 Jul 2026 | Longcor Jarrod | Chief Operating Officer | A-Award | Acquired | 118,000 | $3.14 |
| 8 Jul 2026 | Swirsky Douglas J | director | A-Award | Acquired | 37,500 | $2.70 |
| 8 Jul 2026 | NEIS JOHN | director | A-Award | Acquired | 25,000 | $2.70 |
| 8 Jul 2026 | Loren Stefan | other: Consultant | A-Award | Acquired | 15,000 | $2.68 |